Tag Archives: Roche

12Jan/22

Roche receives MDR certification for its science-based smartphone app Floodlight MS


Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Floodlight™ MS, a smartphone app that enables data-driven clinical conversation and healthcare provider decision-making on a patient’s multiple sclerosis (MS), has achieved MDR certification. MDR certification is required to commercialise medical devices in the European Union. Continue reading

18May/21

Roche receives FDA authorisation for testing of asymptomatic people with the cobas SARS-CoV-2 Test to help control the spread of COVID-19

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its cobas® SARS-CoV-2 Test for use on the widely available, high-throughput cobas® 6800/8800 Systems has received Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA) for testing individuals without symptoms or reasons to suspect COVID-19. Continue reading